Norwegian University of Science and Technology: Headache trials
The registry lists 10 Headache studies with Norwegian University of Science and Technology as lead sponsor. 1 are open to participants now and 2 have results posted.
Phase 1 4Phase 2 6Phase 3 1No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Cluster HeadacheRecruitingNCT03944876Phase 3
- Medication-overuse Headache: 4 Years Follow upCompletedNCT00918671Results posted
- Medication-overuse Headache (MOH): Withdrawal or Use of Preventative Medications Directly?CompletedNCT00159588Not applicableResults posted
- Botulinum Toxin Type A Block of the Otic Ganglion in Chronic Cluster Headache: Safety IssuesCompletedNCT03066635Phase 1/2
- Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Trigeminal Neuralgia. Safety Issues.CompletedNCT02662972Phase 1/2
- Glycerol Block of the Trigeminal Ganglion in Trigeminal Neuralgia Using a New Neuronavigation-based Surgical TechniqueTerminatedNCT02624661Phase 1/2
- Botox Injection in Treatment of Cluster HeadacheCompletedNCT02019017Phase 1/2
- Effects of Pretreatment With Ibuprofen in Post-Electroconvulsive Therapy (ECT) HeadacheWithdrawnNCT00258791Not applicable
- Prophylactic Treatment of Episodic Cluster HeadacheCompletedNCT00184587Phase 2
- Botulinum Toxin Injection in Neck Muscles in Cervicogenic HeadacheCompletedNCT00184197Phase 2